非酒精性脂肪肝炎-话题@MedSci

#非酒精性脂肪肝炎#

10篇内容 | 938人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1556633, encodeId=02e515566332a, content=<a href='/topic/show?id=9ec399e2727' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝炎#</a>, objectTitle=J HEPATOL：丁秋蓉课题组发现治疗非酒精性脂肪肝炎的潜在新靶点, objectType=article, longId=737239, objectId=f3c5e372394d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3c5e372394d, replyNumber=0, likeNumber=30, createdTime=2022-08-30, rootId=0, userName=linagood, userId=661b14811526, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3c5e372394d, moduleTitle=J HEPATOL：丁秋蓉课题组发现治疗非酒精性脂肪肝炎的潜在新靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3c5e372394d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1556632, encodeId=7c051556632e8, content=<a href='/topic/show?id=9ec399e2727' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝炎#</a>, objectTitle=J Hepatol：MRG15可能是非酒精性脂肪肝炎的新潜在靶点, objectType=article, longId=737016, objectId=2be3e37016c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2be3e37016c3, replyNumber=0, likeNumber=46, createdTime=2022-08-27, rootId=0, userName=linagood, userId=661b14811526, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2be3e37016c3, moduleTitle=J Hepatol：MRG15可能是非酒精性脂肪肝炎的新潜在靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2be3e37016c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1556631, encodeId=f529155663150, content=<a href='/topic/show?id=9ec399e2727' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝炎#</a>, objectTitle=Gastroenterology：新研究揭示非酒精性脂肪肝炎的有效治疗靶标和血清诊断标志物, objectType=article, longId=209227, objectId=150920922eae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=150920922eae, replyNumber=0, likeNumber=30, createdTime=2021-04-01, rootId=0, userName=linagood, userId=661b14811526, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=150920922eae, moduleTitle=Gastroenterology：新研究揭示非酒精性脂肪肝炎的有效治疗靶标和血清诊断标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=150920922eae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1556630, encodeId=b23c1556630a0, content=<a href='/topic/show?id=9ec399e2727' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝炎#</a>, objectTitle=Cell Death Differ：RIP1激酶通过介导巨噬细胞死亡和炎症反应促进非酒精性脂肪肝炎的发生, objectType=article, longId=203773, objectId=d5bc203e7384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5bc203e7384, replyNumber=0, likeNumber=41, createdTime=2020-11-27, rootId=0, userName=linagood, userId=661b14811526, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5bc203e7384, moduleTitle=Cell Death Differ：RIP1激酶通过介导巨噬细胞死亡和炎症反应促进非酒精性脂肪肝炎的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5bc203e7384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1556629, encodeId=98bb1556629fb, content=<a href='/topic/show?id=9ec399e2727' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝炎#</a>, objectTitle=CELL METAB：胆固醇稳定TAZ表达，促进非酒精性脂肪肝炎, objectType=article, longId=191731, objectId=515b191e3123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=515b191e3123, replyNumber=0, likeNumber=35, createdTime=2020-04-10, rootId=0, userName=linagood, userId=661b14811526, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=515b191e3123, moduleTitle=CELL METAB：胆固醇稳定TAZ表达，促进非酒精性脂肪肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=515b191e3123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1556628, encodeId=f2d1155662826, content=<a href='/topic/show?id=9ec399e2727' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝炎#</a>, objectTitle=Cell Death Dis：ACER3通过降低细胞氧化应激反应缓解非酒精性脂肪肝炎, objectType=article, longId=191302, objectId=b9481913022f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9481913022f, replyNumber=0, likeNumber=26, createdTime=2020-04-04, rootId=0, userName=linagood, userId=661b14811526, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9481913022f, moduleTitle=Cell Death Dis：ACER3通过降低细胞氧化应激反应缓解非酒精性脂肪肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9481913022f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1556627, encodeId=6dda155662e97, content=<a href='/topic/show?id=9ec399e2727' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝炎#</a>, objectTitle=歌礼新药治疗非酒精性脂肪肝炎（NASH）即将进入临床, objectType=article, longId=188487, objectId=0b7518848e5b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b7518848e5b, replyNumber=0, likeNumber=41, createdTime=2020-02-22, rootId=0, userName=linagood, userId=661b14811526, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b7518848e5b, moduleTitle=歌礼新药治疗非酒精性脂肪肝炎（NASH）即将进入临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b7518848e5b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1556626, encodeId=189a155662677, content=<a href='/topic/show?id=9ec399e2727' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝炎#</a>, objectTitle=BMC Complement Altern Med：牛磺酸联合茶多酚改善非酒精性脂肪肝炎, objectType=article, longId=113077, objectId=e04f1130e742, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e04f1130e742, replyNumber=0, likeNumber=29, createdTime=2017-09-19, rootId=0, userName=linagood, userId=661b14811526, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e04f1130e742, moduleTitle=BMC Complement Altern Med：牛磺酸联合茶多酚改善非酒精性脂肪肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e04f1130e742)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1556625, encodeId=5b87155662589, content=<a href='/topic/show?id=9ec399e2727' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝炎#</a>, objectTitle=我国非酒精性脂肪肝炎研究获突破 1.5亿患者将受益, objectType=article, longId=90142, objectId=f76a9014251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f76a9014251, replyNumber=0, likeNumber=29, createdTime=2017-03-01, rootId=0, userName=linagood, userId=661b14811526, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f76a9014251, moduleTitle=我国非酒精性脂肪肝炎研究获突破 1.5亿患者将受益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f76a9014251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1556624, encodeId=7885155662484, content=<a href='/topic/show?id=9ec399e2727' target=_blank style='color:#2F92EE;'>#非酒精性脂肪肝炎#</a>, objectTitle=Cenicriviroc能改善非酒精性脂肪肝炎患者的纤维化情况，且不会导致脂肪性肝炎恶化, objectType=article, longId=82424, objectId=ba198242438, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba198242438, replyNumber=0, likeNumber=0, createdTime=2016-11-17, rootId=0, userName=linagood, userId=661b14811526, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba198242438, moduleTitle=Cenicriviroc能改善非酒精性脂肪肝炎患者的纤维化情况，且不会导致脂肪性肝炎恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba198242438)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

非酒精性脂肪肝炎

2020-05-29

linagood (审核中...)

前往app查看评论内容

#非酒精性脂肪肝炎#

J HEPATOL：丁秋蓉课题组发现治疗非酒精性脂肪肝炎的潜在新靶点

2022-08-30

linagood (审核中...)

前往app查看评论内容

#非酒精性脂肪肝炎#

J Hepatol：MRG15可能是非酒精性脂肪肝炎的新潜在靶点

2022-08-27

linagood (审核中...)

前往app查看评论内容

#非酒精性脂肪肝炎#

Gastroenterology：新研究揭示非酒精性脂肪肝炎的有效治疗靶标和血清诊断标志物

2021-04-01

linagood (审核中...)

前往app查看评论内容

#非酒精性脂肪肝炎#

Cell Death Differ：RIP1激酶通过介导巨噬细胞死亡和炎症反应促进非酒精性脂肪肝炎的发生

2020-11-27

linagood (审核中...)

前往app查看评论内容

#非酒精性脂肪肝炎#

CELL METAB：胆固醇稳定TAZ表达，促进非酒精性脂肪肝炎

2020-04-10

linagood (审核中...)

前往app查看评论内容

#非酒精性脂肪肝炎#

Cell Death Dis：ACER3通过降低细胞氧化应激反应缓解非酒精性脂肪肝炎

2020-04-04

linagood (审核中...)

前往app查看评论内容

#非酒精性脂肪肝炎#

歌礼新药治疗非酒精性脂肪肝炎（NASH）即将进入临床

2020-02-22

linagood (审核中...)

前往app查看评论内容

#非酒精性脂肪肝炎#

BMC Complement Altern Med：牛磺酸联合茶多酚改善非酒精性脂肪肝炎

2017-09-19

linagood (审核中...)

前往app查看评论内容

#非酒精性脂肪肝炎#

我国非酒精性脂肪肝炎研究获突破 1.5亿患者将受益

2017-03-01

linagood (审核中...)

前往app查看评论内容

#非酒精性脂肪肝炎#

Cenicriviroc能改善非酒精性脂肪肝炎患者的纤维化情况，且不会导致脂肪性肝炎恶化

2016-11-17

科室
- - 订阅+
  - 更多科室
工具
服务